APA (7th ed.) Citation

KJ, O., WJ, I., O, A., T, A., A, B., MP, M., . . . BR, G. (2018). Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis. Molecular genetics and metabolism, 125(1-2), 168. https://doi.org/10.1016/j.ymgme.2018.07.012

Chicago Style (17th ed.) Citation

KJ, O'Brien, et al. "Prolonged Treatment with Open-label Pirfenidone in Hermansky-Pudlak Syndrome Pulmonary Fibrosis." Molecular Genetics and Metabolism 125, no. 1-2 (2018): 168. https://doi.org/10.1016/j.ymgme.2018.07.012.

MLA (9th ed.) Citation

KJ, O'Brien, et al. "Prolonged Treatment with Open-label Pirfenidone in Hermansky-Pudlak Syndrome Pulmonary Fibrosis." Molecular Genetics and Metabolism, vol. 125, no. 1-2, 2018, p. 168, https://doi.org/10.1016/j.ymgme.2018.07.012.